P&G Health Ltd. manufactures and sells medications and chemicals.
Financial Results:
- Procter & Gamble Health Limited reported Total Income for Q4FY23 of ₹ 326 Crores up from ₹ 270 Crore year on year, a rise of 21%.
- Total Expenses for Q4FY23 of ₹ 247 Crores up from ₹ 205 Crores year on year, rise of 20.5%.
- Consolidated Net Profit of ₹ 59 Crores, up 16% from ₹ 51 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹ 35.7, up 16% from ₹ 30.8 in the same quarter of the previous year.
